← Back to directory

Luc Mouthon

Researcher Next ID · RN-032585

Researcher · Medicine

Délégation Paris 5

Paris, France

Accepting doctoral researchersFunding unknown
Works count
1,249
Citation count
47,575
H-index
107
i10-index
533

Research interests

Medicine
Systemic Sclerosis and Related Diseases
Vasculitis and related conditions
Inflammatory Myopathies and Dermatomyositis
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Systemic Lupus Erythematosus Research

Publications

  • Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies

    Nature Medicine · 2022 · 10.1038/s41591-022-01792-5

  • Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

    Science · 2020 · https://doi.org/10.1126/science.abc6027

  • Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data

    BMJ · 2020 · https://doi.org/10.1136/bmj.m1844

  • Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19

    Cell · 2020 · https://doi.org/10.1016/j.cell.2020.08.002

  • Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients

    medRxiv · 2020 · https://doi.org/10.1101/2020.04.19.20068015

  • Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

    Annals of the Rheumatic Diseases · 2018 · https://doi.org/10.1136/annrheumdis-2017-212878

  • Mapping and predicting mortality from systemic sclerosis

    Annals of the Rheumatic Diseases · 2017 · https://doi.org/10.1136/annrheumdis-2017-211448

  • European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes

    Journal of the European Academy of Dermatology and Venereology · 2017 · 10.1111/jdv.14458

  • Eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management

    European Journal of Internal Medicine · 2015 · 10.1016/j.ejim.2015.04.022

  • Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

    New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1404231

  • Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort

    Arthritis & Rheumatism · 2012 · https://doi.org/10.1002/art.37721

  • Short‐term and long‐term outcomes of interstitial lung disease in polymyositis and dermatomyositis: A series of 107 patients

    Arthritis & Rheumatism · 2011 · 10.1002/art.30513

  • Clinical features and outcomes in 348 patients with polyarteritis nodosa: A systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French vasculitis study group database

    Arthritis & Rheumatism · 2010 · 10.1002/art.27240

  • The Five-Factor Score Revisited

    Medicine · 2010 · https://doi.org/10.1097/md.0b013e318205a4c6

  • Inflammation, Growth Factors, and Pulmonary Vascular Remodeling

    Journal of the American College of Cardiology · 2009 · 10.1016/j.jacc.2009.04.006

  • Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis

    Yearbook of Medicine · 2008 · 10.1016/s0084-3873(09)79350-2

  • Vasculitides associated with malignancies: Analysis of sixty patients

    Arthritis Care & Research · 2007 · 10.1002/art.23085

  • Churg‐Strauss syndrome with poor‐prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty‐eight patients

    Arthritis Care & Research · 2007 · 10.1002/art.22679

  • Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis

    Blood · 2007 · 10.1182/blood-2007-03-079947

  • Intravenous Immunoglobulin: An Update on the Clinical Use and Mechanisms of Action

    Journal of Clinical Immunology · 2007 · 10.1007/s10875-007-9088-9

  • Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

    Arthritis & Rheumatism · 2005 · https://doi.org/10.1002/art.21433

  • Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss Syndrome

    Annals of Internal Medicine · 2005 · https://doi.org/10.7326/0003-4819-143-9-200511010-00006

  • Common Variable Immunodeficiency Patient Classification Based on Impaired B Cell Memory Differentiation Correlates with Clinical Aspects

    Journal of Clinical Immunology · 2003 · 10.1023/a:1025373601374

  • Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: A prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty‐five patients

    Arthritis Care & Research · 2003 · 10.1002/art.10922

  • Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin

    Blood · 2002 · 10.1182/blood-2002-05-1447

  • Self-reactive antibodies (natural autoantibodies) in healthy individuals

    Journal of Immunological Methods · 1998 · 10.1016/s0022-1759(98)00074-x

Current projects

    No projects listed.